Korea Investment Partners

Korea Investment Partners (KIP) is a prominent venture capital and private equity firm with over 30 years of experience in supporting innovative entrepreneurs. Established in 1986, KIP has made significant investments in notable companies, including Kakao, Naver, YG Entertainment, Bodyfriend, and Didi Chuxing. The firm manages more than 20 venture and private equity funds, overseeing total assets of approximately $1.8 billion. Headquartered in Seoul, KIP also has offices in Shanghai, Beijing, and Sunnyvale, enabling it to operate on a global scale. The firm is recognized as one of the leading venture capital investors in South Korea, focusing on empowering bold ventures that aim to make a transformative impact.

Yer-hyun Baek

CEO and President

Yer Hyun Baek

President

Hak Sung Chang

Director

Steve Hong

Manager

Man-soon Hwang

Senior Managing Director and Venture Director

Sang Hyuk Jang

Associate

Hyeong-sun Jeon

Principal

Seung-hi Kang

Director of Venture Group 1 & Venture Partner

Jae Hong Kim

Private Equity Managing Director

Chang-ho Kim

Executive Director and Venture Partner

Yong-Jae Kim

Head of Management Support, MD

Min-kyu Kim

Director

Hwang Kim

Executive Director, Corporate Management

Kun-ho Kim

Principal

Dong-yeob Kim

Executive Director

Won-Bae Lee

Executive Director

Ke Liu

Principal

Jin-han Park

Senior Principal

Young-ho Park

Senior Principal

Hyeong-jun Park

Principal

Minsik Park

Director

Ji Woong Park

Senior Principal

Deok Joon Shin

Director

Deok-joon Shin

Director

Ping Wang

Associate Partner

Jerry Hai Xu

Principal and Director

Sung-wook Yoo

Principal

484 past transactions

Matchmade

Series A in 2018
The time for performance-driven influencer marketing is here. Matchmade is an easy-to-use platform that brings advertisers and influencers together for targeted and measured campaigns.

Youyiche Holdings

Series A in 2014
Youyiche Holdings

Frequency Therapeutics

Series A in 2017
Frequency Therapeutics develops small molecule drugs that activate progenitor cells within the body to restore healthy tissue. Through the transitory activation of these progenitor cells, Frequency enables disease modification without the complexity of genetic engineering. It was founded in 2015 and headquartered in Woburn, Massachusetts.

ABL Bio

Series B in 2017
ABL Bio Inc., a biotech research company, focuses on the development of therapeutic drugs for immuno-oncology and neurodegenerative diseases. Its pipeline drugs include ABL001, cancer immunotherapy, ADC, and ABL301. The company is headquartered in Seongnam, South Korea.

OncXerna Therapeutics, Inc.

Private Placement in 2019
OncXerna Therapeutics, Inc. develops and delivers precision medicines for cancer patients by prospectively identifying patients based on RNA-based biology of their tumor microenvironments. It predicts patient responses for potentially first-in-class targeted oncology therapies through an RNA-based biomarker platform. The company was formerly known as Oncologie, Inc. and changed its name to OncXerna Therapeutics, Inc. in September 2020. OncXerna Therapeutics, Inc. was founded in 2018 and is based in Waltham, Massachusetts with an additional location in Shanghai, China.

Jaranda

Series B in 2022
Jaranda Co., Ltd. owns and operates a platform that integrates teachers, parents, and students. The company is based in Seoul, South Korea.

KMW

Private Placement in 2018
Kmw Inc. develops and produces equipment, and parts and components for mobile communication base stations. Its products include filters, such as macro filters, black hole filters, micro bellows filters, and other products; site solutions that include multi-port antennas, omnidirectional antennas, and combiners, as well as other solutions, such as fixed clamps, adjustable clamps, 3 sector clamps, enhanced portable AISG controllers, and remote control tilting and steering products; and RRH, MMR, and RRA systems. It serves customers in Korea, the United States, Europe, and Asia. Kmw Inc. was founded in 1991 and is headquartered in Hwaseong, South Korea.

Humanscape

Private Placement in 2020
Humanscape is a rare disease health-tech company working to bring better chances of cure for patients. By collecting comprehensive patient health data from genotype, clinical to phenotype data and systematically compiling it into a complete, ready-to-use data set, pharmaceuticals and researchers can significantly reduce both time and cost for new drug development.

Actym Therapeutics, Inc.

Series A in 2020
Actym is a biotechnology company that focuses on developing an immuno-oncology platform. It specializes in the fields of medical device, manufacturing, and distribution. It focuses on a novel tumor-targeting, systemically-delivered STING pathway agonist that demonstrates robust anti-tumor. It was founded in 2017 and headquartered in San Francisco, California.

Smart Radar System

Private Placement in 2020
Smart Radar System (SRS) is a pioneer in the field of 4D image radar. Having specialized in radar technology for more than three years, SRS is developing the world's first 4D image radar, RETINA, with sub 1 degree angular resolution and 360 degree surround view.

Action Square

Series A in 2013
Action Square CO., LTD. develops mobile games in South Korea. It offers various games, such as blade, Three Kingdoms Blade, Blade 2, and Gigantic X. The company was founded in 2012 and is based in Seongnam, South Korea.

G2GBIO

Series A in 2018
G2GBIO operates to supply good medicines to patients all over the world and practice.

Immotor

Private Placement in 2018
SZ IMMOTOR Technology Co., Ltd. develops and sells portable and personal transport systems. Its products include Immotor GO, a portable motorized scooter; Immotor Super Battery, a power management source; and Immotor Cloud, a remote control and fleet management tool for Immotor GO. SZ IMMOTOR Technology Co., Ltd. was founded in 2016 and is based in Shenzhen, China.

Meixin Global

Series A in 2017
Founded in 2015, Meixin provides a number of global wealth management products such as fixed income investments, real estate private equity fund, private equity investments and overseas hedge funds to Chinese high-net-worth individual clients. It also has a business-to-business platform providing global asset analysis and trading services for financial institutions such as asset management companies.

Meixin Global

Private Placement in 2019
Founded in 2015, Meixin provides a number of global wealth management products such as fixed income investments, real estate private equity fund, private equity investments and overseas hedge funds to Chinese high-net-worth individual clients. It also has a business-to-business platform providing global asset analysis and trading services for financial institutions such as asset management companies.

Lifegoeson Company Corp.

Private Placement in 2020
Lifegoeson Company Corp. operates an application that offers online laundering services. The company is based in Seoul, South Korea.

TEMCO Labs

Seed Round in 2018
TEMCO is a Blockchain-based supply and e-commerce open market platform. They aim to revolutionize supply chain management through innovative technology using Blockchain and smart contracts. TEMCO project will provide greater transparency and reliability across the supply chain process to deliver trustworthy information that empowers businesses and consumers.

Remember

Venture Round in 2015
Remember is the number one business card management application in Korea that secretary inputs directly when you take a business card.

Infit & Company Inc.

Series A in 2018
Infit & Company Inc. is a manufacturer of medical diagnostic devices and wellness devices that targeting global healthcare industry.

S-Alpha Therapeutics

Series A in 2021
S-Alpha Therapeutics Inc., a digital therapeutics company, researches and develops health applications and platform technologies that enable digital devices to treat different diseases. Its products include SAT-001, an ophthalmology related application for eye disease treatment; SAT-002, neurology application for treatment of nervous system disease; SAT-003, oncology application for recovery and treatment of cancer patients; and SAT-008, a public crisis application for overcoming social problems. Additionally, it also develops therapeutic devices. The company was founded in 2019 and is based in Seoul, South Korea.

Tiki

Series C in 2018
Tiki Corporation retails books, electronics, home appliances, gifts, fashion, beauty, and health products. The company also offers phone, digital equipment and accessories, electrical appliances, life house products, beauty and health products, stationery, vehicles, toys and souvenirs, mother and baby sports products, air ticket booking, and international goods. It sells its products through online store. The company was founded in 2010 and is based in Ho Chi Minh City, Vietnam.

wadiz

Venture Round in 2017
Wadiz Corp. operates a crowdfunding platform for start ups. The company was incorporated in 2012 and is based in Seongnam, South Korea.

MicuRx Pharmaceuticals

Private Placement in 2020
MicuRx Pharmaceuticals, Inc., a biopharmaceutical company, discovers and develops antibiotics for drug-resistant bacterial infections. It offers MRX-I, an oral antibiotic for gram-positive bacterial infections that exhibits high activity against multi-drug resistant gram-positive pathogens, including methicillin-resistant staphylococcus aureus and vancomycin-resistant enterococci. The company also provides MRX-IV, a water-soluble prodrug form of MRX-I that is intended for intravenous use; MRX-V, an injectable antibiotic active against gram-negative bacteria; and MRX-VIII, a polymyxin for gram-negative infections. In addition, its pipeline of antibacterial drugs combats gram-positive and gram-negative bacterial pathogens. MicuRx Pharmaceuticals, Inc. was founded in 2007 and is based in Palo Alto, California. It has research and development facilities outside San Francisco, California; and Shanghai, China.

Shawya

Series A in 2019
Shawya is a skin care brand operator, which has a variety of product lines such as skin care, beauty, maternal and child, to meet the needs of users.

Crowdworks

Series B in 2019
CrowdWorks, Inc. develops online crowd sourcing platform for artificial intelligent (AI) which engages in collecting, strengthening, and structuring leaning data for machine learning. The company offers its services for analysis and classifying of image works, text works, voice works, and survey works. The company is based in Seoul, South Korea.

Happyeasygo

Series B in 2019
HappyEasyGo is an India based local Online Travel Company. We are providing best air tickets and hotels with the lowest Price. Now you can book various airline tickets such as IndiGo, Jet airways, Go air, Spice Jet, air Asia, Vistara and Air India. We also provide you updated and verified Happy Easy Go instant discount hotels and special offers on flight tickets.

TEMCO Labs

Private Placement in 2018
TEMCO is a Blockchain-based supply and e-commerce open market platform. They aim to revolutionize supply chain management through innovative technology using Blockchain and smart contracts. TEMCO project will provide greater transparency and reliability across the supply chain process to deliver trustworthy information that empowers businesses and consumers.

PDC*line Pharma

Series B in 2020
PDC*line Pharma is a French-Belgium clinical-stage biotech company that develops a new class of active immunotherapies for cancer based on an allogeneic cell line of Plasmacytoid Dendritic cells (PDC*line) loaded with cancer antigens. PDC*line Pharma originated from a flagship R&D program of the French Blood Bank (EFS, Etablissement Français du Sang) where PDC*line, a proprietary Plasmacytoid Dendritic Cell line (PDC) was developed from a patient with a PDC leukemia. Laurent LEVY President France & COO, and Joel PLUMAS, CSO founded the company in April 2014 in Grenoble and took the project to the clinical development stage with non-dilutive funding. Eric Halioua joined the team in February 2016, and became President and CEO in July 2016.

TonyMoly

Series A in 2015
"TONYMOLY is a global cosmetic company where their mission is to perfect the skin. Confidence comes through radiant skin and they insist on trying their best to offer the best skin products through research for their consumers." As we age, everyone wants to keep and maintain our youthful skin. Youthful glow to our skin often becomes our reminiscence as we age. TONYMOLY strives through research and ethical skin care principles to offer the fountain of youth in careful selection of their products. They focus on how to offer this youthful complexion for their consumers to maintain radiant, glowing, and renewed skin.

Fount

Series A in 2016
Fount Inc. Is an asset management Robo-Advisor startup founded in 2015. Their investing algorithm based on BigData Technology helps you plan for every event of your life. fount team believes in passive investing, which takes the right level of risk for your goal's time horizon, and allows their advanced computer algorithms do all the work.

Haitun Dingnai

Series A in 2019
Dolphin ordering milk is a mobile-based application platform that allows its users to order domestic milk. Its software platform integrates consumer demand for milk it connects domestic and foreign milk production enterprises.

EuBiologics Co., Ltd.

Series B in 2014
Privately‐held Korean biopharmaceutical company providing CRMO services and developing a portfolio of vaccines for global public health.

Bifrost

Seed Round in 2019
Bifrost is a full developer suite for multichain DApp development, liberating blockchain developers from currently constrained infrastructure for specific blockchain networks.

Innogen Pharmaceutical

Venture Round in 2021
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

Fast Five

Series E in 2021
Fast Five is a premium SOHO office business center that aims to become an offline social network based on Fast Five membership. FAST FIVE is a membership-based premium SOHO office that offers a great business space at a reasonable price without deposit. At FAST FIVE, they aim to become an offline social network that creates a strong bond through a community manager who resides to create friends and partners with famous people from various fields such as founders, investors, professionals, and freelancers.

Geneos Therapeutics

Series A in 2022
Geneos is developer of a neo-antigen based personalized immunotherapy designed to offer cancer treatment. The company's technology is designed to identify relevant neoantigen targets from individual patient tumors to develop novel treatments for cancer, providing patients with tumor targeted immunotherapies to cure their disease.

Newlink

Series D in 2020
Newlink primarily operates as a digital energy service provider. It promotes energy change, the energy Internet of Things EIoT, and an energy new retail platform. It is a dual-material unicorn at home and abroad, one of the world's top 500 new energy companies, with more than 3,000 employees. Covering oil, electricity, hydrogen, and gas multiple energy categories, opening up the upstream and downstream of the energy industry chain, and digitally reconstructing the energy ecology.

Supertree

Private Placement in 2020
Supertree world’s first gaming platform built using meta-blockchain technology such as ETH, EOS, etc. We are building a next-generation gaming platform with a vision for a truly decentralized service focusing on three points: decentralized Identity, decentralized Ledger and decentralized CDN.

Enlivex Therapeutics

Series B in 2017
Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells. Enlivex is developing an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn's Disease, and other autoimmune and inflammatory disorders. The company's revolutionary approach to inducing immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.

Zhenge Biotech

Series A in 2020
Shanghai ZhenGe Biotechnology Co.,Ltd. researches and develops drugs. It also engages in mammalian cell line development, upstream development, downstream development, and formulation development for various protein therapeutics. In addition, the company provides contract development and manufacturing services; and offers IND and BLA filing services. Further, it provides platform for research and development of antibodies, transient infection, process development, N-Glycosylation, and CAR-T. Shanghai ZhenGe Biotechnology Co.,Ltd. was founded in 2017 and is based in Shanghai, China.

Twiggle

Series B in 2017
Twiggle Ltd. develops a search technology that allows a search engine mimic a salesperson. It offers a natural language analyzer that uses natural language processing to extract linguistic intent from customer queries and a universal product ontology for product search. The company provides Twiggle's Semantic API, a plug-and-play semantic search application programming interface (API) that integrates into existing search engines and provides a natural language layer that allows search engineers and data scientists to enhance search logic and present results to shoppers. Twiggle Ltd. was founded in 2013 and is headquartered in Tel Aviv, Israel with an additional office in New York, New York.

Elastagen

Series B in 2016
Elastagen Pty Ltd., a clinical stage medical company, produces and sells products based on the human protein tropoelastin. The company offers injectable dermoaesthetic products, stretch mark products, scar revision and wound healing products, and sealant and osteoskeletal products for applications areas, including skin rejuvenation, scar remodeling, and tissue repair. It sells its products through online orders. Elastagen Pty Ltd. was founded in 2003 and is based in Eveleigh, Australia with production operations in Europe; and clinical operations in the United Kingdom. As of April 6, 2018, Elastagen Pty Ltd. operates as a subsidiary of Allergan plc.

JOYCITY Corporation (KOSDAQ:A067000)

Private Placement in 2020
JOYCITY Corporation operates as a gaming company worldwide. It designs, develops, and services games for multiple platforms, including PC online, mobile, VR, and console. The company was formerly known as JC Entertainment Corp and changed its name to JOYCITY Corporation in June 2013. JOYCITY Corporation was founded in 1994 and is based in Seongnam-si, South Korea.

Traplight Oy

Venture Round in 2017
Traplight Oy develops mobile game communities where players can create and share their own games with their friends. Traplight Oy was incorporated in 2010 and is based in Tampere, Finland.

Systran

Private Placement in 2020
Since its foundation in 1968, SYSTRAN has been pioneering machine translation technology. The company leads the industry with a number of breakthrough innovations and solutions now commonly used by companies and consumers. With a strong focus on research and development, SYSTRAN is 50 years later, more innovative than ever. Now introducing its Neural Machine Translation enterprise solution, SYSTRAN is bringing the capabilities of Neural translation to corporate users.

Univercells

Private Placement in 2018
Univercells is a One-stop-shop for high-density low-cost biomanufacturing "end-to-end" solutions, with innovative engineering able to decrease the needs for investments of over 75% and the cost of goods of up to 90%. Univercells' technologies, aimed at low cost manufacturing of antibodies/proteins/vaccines, is based on single-use technologies, and chaining of three manufacturing steps into simulated continuous mode : cell culture under perfusion, clarification and capture.

Tapas Media

Series B in 2019
Tapas Media, Inc. owns and operates, Tapastic, an online platform and community for indie comic artists and visual storytellers. It specializes in creating visual stories online. The company was founded in 2012 and is based in San Francisco, California.

Four33

Series A in 2013
4:33 Ltd. (네시삼십삼분) is a Korean social entertainment media company with over 10 years of experience in mobile and online game development.

OncXerna Therapeutics

Series B in 2019
OncXerna Therapeutics offers precision medicine using an innovative RNA-based biomarker platform. OncXerna Therapeutics is aiming to deliver next-generation precision medicine for a larger group of cancer patients by leveraging the company’s deep understanding of how to prospectively identify patients based on the dominant biology of their tumor microenvironments. This allows OncXerna to pair those patients with OncXerna’s clinical-stage therapies with known mechanisms of action that directly address these biologies, to dramatically improve patient outcomes. The company was founded in 2018 and was formerly known as Oncologie.

Swiggy

Series I in 2020
Swiggy designs an on-demand food delivery platform that brings food from neighborhood restaurants directly to users' doors. The company's food delivery platform lists local restaurants and menu lists on an app for users to order from and track delivery of its delivery executives, enabling users to order food with speed and convenience. Its service is used to pick up and drop off a diverse array of items, including laundry and document or parcel deliveries to business clients and retail customers. Swiggy was founded by Sriharsha Majety, Nandan Reddy, and Rahul Jaiminiin in 2014 and is headquartered in Bangalore, Karnataka, India.

Oasis Market

Private Placement in 2020
Oasis Co., Ltd. operates as an online grocery delivery platform. It offers convenience food, agricultural products, livestock, aquatic products, health/beverage, seasoning, general food, and side dishes. The company also operates offline stores and provides early morning delivery. The company was founded in 2011 and is based in Seoul, South Korea. Oasis Co., Ltd. operates as a subsidiary of GaeaSoft Corp.

Rabbit Care

Series B in 2020
Rabbit Care is your first choice for insurance and banking advise. We provide great customer experience through our digital platform and customer care center.

Halodoc

Private Placement in 2019
PT HaloDoc provides a communication platform that connects patients with doctors. It offers HaloDoc that enables users to connect with doctors through video calls, voice calls, and chat; order laboratory tests; and find the closest hospitals, clinics, and doctors. It also offers its service through its Website. PT HaloDoc was founded in 2016 and is based in Jakarta, Indonesia.

MEDIHERE

Private Placement in 2020
MEDIHERE Inc. provides online healthcare consultation services. It offers a subscription based service that provides patients with doctor's appointments and prescriptions with board-certified physicians who speak Korean and English. The company’s services are used by patients with chronic diseases and patients who find it hard to explain their symptoms due to language barrier. The company also provides B2B Program for enterprises that provides virtual primary care via chat/video call for employers. The company was incorporated in 2018 and is based in Seoul, South Korea.

eBrace

Private Placement in 2020
Guangzhou eBrace Biotechnology Co., Ltd. engages in the research, development, production, and sale of orthodontic biological materials. It offers 3D custom printing orthodontic teeth products. The company was founded in 2010 and is based in Guangzhou, China.

Innogen Pharmaceutical

Venture Round in 2022
Innogen Pharmaceutical Technology is a high-tech, innovation-driven international pharmaceutical manufacturing, and R&D company.

Enlivex Therapeutics

Private Placement in 2019
Enlivex is an Israeli-based cell immunotherapy company established in October 2005 by Professor Dror Mevorach, a world-renowned expert on clearance of dying (apoptotic) cells. Enlivex is developing an autologous and allogeneic drug pipeline for the treatment of autoimmune and inflammatory conditions such as Graft versus Host Disease (GvHD), solid organ transplant rejection, Crohn's Disease, and other autoimmune and inflammatory disorders. The company's revolutionary approach to inducing immune tolerance by injecting apoptotic cells and facilitating their interaction with dendritic cells activates the body's innate, physiologic mechanism for down-regulating inflammation and autoimmunity.

ExcelMab

Series A in 2020
Guangzhou Excelmab Biomedical Technology Co., Ltd. develops anti-tumor bispecific antibody drug. The company was incorporated in 2016 and is based in Guangzhou, China.

eBrace

Series B in 2020
Guangzhou eBrace Biotechnology Co., Ltd. engages in the research, development, production, and sale of orthodontic biological materials. It offers 3D custom printing orthodontic teeth products. The company was founded in 2010 and is based in Guangzhou, China.

KAHR medical

Series B in 2015
KAHR medical Ltd., an immuno-oncology drug development company, develops and manufactures fusion protein pharmaceuticals for the treatment of cancer and autoimmune diseases. It offers DSP105 and DSP 106 that are used for T-cell mediated tumor destruction; and DSP 107 that targets CD47 tumors activating phagocytes and delivering an immune costimulatory signal. The company was founded in 2005 and is based in Jerusalem, Israel.

Inflearn

Series A in 2021
Operator of an online education platform intended for sharing and teaching IT knowledge. The company's platform has lectures conducted by expert IT personnel on various topics like python and data analytics, enabling students to reach out to IT experts who are willing to share their domain expertise.

XYZ

Series A in 2022
LoungeLAB is a Retail-tech startup that augments space with technology, using the state-of-the-art technologies such as AI and Robotics technology. LoungeLAB focuses on enhancing the product value and services, and we develop in the field rather than on the desk. We Invent Everyday Technology for All.

It's Skin

Series A in 2015
It'S SKIN Co., Ltd. manufactures and distributes skin care products in South Korea and internationally. The company offers skin care products, including eye, sun care, cleansing, mask, and special care products; base and point make up products; nail care and color products; hair and body care products; men and baby care products; and tools, etc.

Laundrygo

Series B in 2020
Laundrygo is a on-demand laundry service.

M.Monstar

Series C in 2019
Developer of a corporate SI platform intended to offer a modular tool. The company offers omnichannel and mobile SCM to build SI (system integration) large shopping malls in a short period of time, enabling clients to integrate shopping mall management.

EJN

Series A in 2020
EJN Corp. owns and operates online community platforms and services for gamers. The company offers e-sports platform Battle.dog, which analyzes the viewing data of e-sports competitions; and Twip an online sales channel for creators and streamers; and Twitch, an online social community for games. It also offers community and payment services for game video streaming services. EJN Corp. was incorporated in 2016 and is based in Seoul, South Korea.

IGAWorks

Series D in 2019
IGAWorks is an full stack ad-tech company founded on 2006, and we are a group of industry-leading global services for the smart success of digital marketing and mobile businesses. We provide full-stack of ad-tech services which follows: ‘Tradingworks’, agency trade desk offering media, audience, performance as total advertisement service; ‘adbrix’, an all-in-one data platform which leads the growth of mobile businesses with data based on the ad performance and user data; ‘adPOPcorn’, the biggest ad network in Korea; ‘Mobile Index‘, mobile app market analytics platform; ‘Campaign Intelligence’, reporting tool which dramatically lessens marketer’s reporting workload. Today, more than 30,000 mobile apps are utilizing the solutions of IGAWorks for their growth of businesses.

NRISE

Seed Round in 2020
NRISE is develops MOCI and WIPPY services. NRISE research and develops social media services to bring people the joy of communication.

Aloha Factory

Seed Round in 2021
Aloha Factory develops hyper-casual games, that are easy and intuitive, so anyone can play them.

Perception Point

Series A in 2018
Perception Point LTD offers cyber security technology that hunts the attackers online. The company is based in Tel Aviv, Israel.

Vaccitech

Venture Round in 2018
Vaccitech Limited researches and develops T cell immunotherapeutic products and vaccines. The company offers hepatitis B virus (HBV) and human papillomavirus (HPV) therapeutic products and therapeutic vaccines for prostate cancer. The company was incorporated in 2016 and is based in Oxford, United Kingdom.

PILAB

Series A in 2022
PILAB is a research-focused blockchain company that develops multipurpose software that enables communication and management of data across different platforms. PILAB is backed by South Korean venture capital firm Korea Investment Partners.

Hisense Bio

Series B in 2019
Hisense Bio offers treatment for intractable dental diseases. They provide research on original technology for tooth development and dentin regeneration. They developed physiological dentin regeneration technology and periodontal ligament regeneration technology based on basic dental research . They offer treatment of intractable dental diseases such as tooth decay, dental hypersensitivity, tooth decay, dental caries, and periodontal disease.

1939 Games

Venture Round in 2021
1939 Games is a indie game development studio based in Reykjavik, Iceland. They are focused on WWII gaming experiences and are currently working on a digital collectible card game that goes by the name of KARDS. The game will draw familiar elements from the card game genre and fuse them with classic WWII gaming for an elegant, action packed and fun card game. 1939 Games was founded around the KARDS project in 2015 by former CCP veterans.

Torder

Seed Round in 2022
Torder is evolving into a next-generation technology leader that allows unattended control of all devices from any location. The business began as a platform for ordering and advertising on tablets.

Reach Robotics

Series A in 2017
Reach Robotics is creating the next gaming platform by combining Robotics, Gaming and AR. This means video game characters in real life that appear to be alive and can engage in various game modes, unlocking lots of potentials. The robots they make are more than connected toys, they are consistently evolving entertainment platforms. Their flagship product, MekaMon, has propelled us to the forefront of consumer robotics and they continue to evolve to ensure the future is always within reach.

D'CENT

Seed Round in 2018
D'CENT provides cryptocurrency hardware wallet for keeping crypto assets secure.

Prokarium

Series B in 2020
Prokarium is a developer of microbial genetics product designed for targeted vaccines and cancer immunotherapies. The company's product generates broad immune responses including mucosal, systemic and cellular immunity for the treatment of solid tumours as well as other oral vaccines, enabling doctors to evaluate the safety and immunogenicity of the bivalent vaccine.

PILAB

Seed Round in 2019
PILAB is a research-focused blockchain company that develops multipurpose software that enables communication and management of data across different platforms. PILAB is backed by South Korean venture capital firm Korea Investment Partners.

Zaksim Library

Venture Round in 2018
Operator of study rooms intended to encourage students to achieve their career goals. The company's study rooms offer a comfortable and open atmosphere with storage space and access to online educational content as well as independent space where concentration is exerted to the extent that one doesn't feel the passage of time, enabling users to have an optimized space that requires concentration and privacy.

Oasis Market

Venture Round in 2020
Oasis Co., Ltd. operates as an online grocery delivery platform. It offers convenience food, agricultural products, livestock, aquatic products, health/beverage, seasoning, general food, and side dishes. The company also operates offline stores and provides early morning delivery. The company was founded in 2011 and is based in Seoul, South Korea. Oasis Co., Ltd. operates as a subsidiary of GaeaSoft Corp.